Porphyria cutanea tarda unmasked by supratherapeutic estrogen during gender-affirming hormone therapy.

Jackson Cullison, Stephanie R; Jedrych, Jaroslaw J; James, Alaina J

Jackson Cullison, Stephanie R; Jedrych, Jaroslaw J; James, Alaina J.

Affiliation

Jackson Cullison SR; Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Jedrych JJ; Department of Dermatology, The Johns Hopkins University, Baltimore, Maryland.
James AJ; Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

JAAD Case Rep ; 6(7): 675-678, 2020 Jul.

Article in En | MEDLINE | ID: mdl-32637521

Key words

HT, hormone therapy; PCT, porphyria cutanea tarda; estradiol; gender minority; hormone therapy; porphyria cutanea tarda; progesterone; transgender

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Aspects: Determinantes_sociais_saude Language: En Journal: JAAD Case Rep Year: 2020 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Aspects: Determinantes_sociais_saude Language: En Journal: JAAD Case Rep Year: 2020 Document type: Article